Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Semaglutide
Related studies linked through entity extraction aliases.
Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of BGM0504 in Early T2DM With Obesity
- Status
- RECRUITING
- Phase
- PHASE3
Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies
- Status
- RECRUITING
- Phase
- NA
Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity
- Status
- COMPLETED
- Phase
- N/A
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Status
- RECRUITING
- Phase
- PHASE3
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
- Status
- RECRUITING
- Phase
- PHASE2
BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Weight Loss in Adults Using Semaglutide (Real-world Study)
- Status
- RECRUITING
- Phase
- N/A
BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
- Status
- RECRUITING
- Phase
- N/A
Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.
- Status
- COMPLETED
- Phase
- N/A
Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk
- Status
- COMPLETED
- Phase
- N/A
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves
- Status
- COMPLETED
- Phase
- PHASE2
Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A